Saturday May 10, 2025
  • |Subscribe
  • |Contribute
  • |About
  • |Access Your Account
  • |Register
  • |Login
  • |Home
  • |Issue Archive
    • |Featured Reports
    • |eBooks
  • |BioProcess Insider
  • |Multimedia
    • |BPI White Papers
    • |Webinars
    • |Posters
  • |BioProcess International Events
    • |BioProcess International US West
    • |BioProcess International Europe
  • |BioProcess International Academy
  • |Events

BioProcess International

Covering the whole development process for the global biotechnology industry

  • Upstream
    Processing
    Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
    • Assays
    • Biochemicals/Raw Materials
    • Bioreactors
    • Cell Culture Media
    • Expression Platforms
    • Fermentation
    • Perfusion Cell Culture
    • Upstream Contract Services
    • Upstream Single-Use Technologies
  • Downstream
    Processing
    Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
    • Filtration
    • Separation/Purification
    • Viral Clearance
    • Chromatography
    • Downstream Contract Services
    • Downstream Single-Use Technologies
  • Manufacturing
    Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
    • Personalized Medicine
    • Single Use
    • Supply Chain
    • Vaccines
    • MAb
    • Biosimilars
    • Cell/Gene Therapies
    • Emerging Therapeutics
    • Facility Design/Engineering
    • Continuous Bioprocessing
    • Fill/Finish
    • Formulation
    • Information Technology
    • Manufacturing Contract Services
    • Process Monitoring and Controls
  • Analytical
    Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
    • Culture Development
    • Cell Line Development
    • Downstream Development
    • Downstream Validation
    • Laboratory Equipment
    • PAT
    • Pre-Formulation
    • Product Characterization
    • QA/QC
    • Upstream Development
    • Upstream Validation
    • Leachables/Extractables/Particulates
  • Business
    Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.
    • Careers
    • CMC Forums
    • Economics
    • Intellectual Property
    • Pre-Clinical and Clinical Trials
    • Regulatory Affairs
    • Risk Management
    • BioRegions

Supporting Advances in MAb Process Development and Manufacturing

View PDF
by BPI Contributor Friday, February 1, 2013  1:41 pm

Mab-white-paper-image-610x4001-610x400
Learn how GE Healthcare Life Sciences is supporting advances in MAb process development and manufacturing, and looking ahead, to Fabs and other antibody fragments that hold promise for new and more effective therapies.

Click to View this White Paper Now

Categories: BPI White Papers, Manufacturing, Sponsored Content

View PDF
← Older Post Newer Post →

Editor’s Choice

  • BioProcess Insider

    Quell and Cellistic partner to develop cell therapy platform

  • BioProcess Insider

    Shingrix sales bounce back post-pandemic for GSK

  • Sponsored Content

    Product Quality in Focus

  • BioProcess Insider

    Danaher and Sartorius: COVID just one variable affecting bioprocess growth

  • BioProcess Insider

    Thermo Fisher opens $44m single-use Utah plant

  • Sponsored Content

    The Critical Role of Predictive Bioreactor Characterization in Pharmaceutical Process-based Upscaling

BioProcess Insider News and Analysis

Recent Tweets

  • Tweet Avatar Great panel discussion about the security of supply chains at the BPI Theatre #BPIWest https://t.co/rMFdNpHjhM 2 years ago
  • Tweet Avatar We’re at #BPIWEST, 2023! 2 years ago
  • Tweet Avatar What a great event #cphi2022 - see you in Barcelona next year! 3 years ago
  • Tweet Avatar We’re here & ready for the second day at #CPHI in Frankfurt! 3 years ago
Follow @bioproinsider

Explore Topics

  • Upstream Processing
  • Downstream Processing
  • Manufacturing
  • Analytical
  • Business

Publication

  • Issue Archive
  • Featured Reports
  • eBooks
  • Subscribe
Connect
Privacy policy

BioProcessIntl.com

  • White Papers
  • Posters
  • Webinars
  • BPI Theater
  • Awards
  • Register
  • Login
  • Access Your Account

Keep up with BPI

  • Email Newsletters
  • Events
  • BioProcess Insider
  • Twitter
  • LinkedIn

About BPI

  • Who We Are
  • Editorial Advisors
  • Author Guidelines
  • Advertising/Media Kit
  • List Rental/Reprints
  • Contact Us
  • Careers
BPI
twitter linkedin
Site Map|Contact
©2025 BioProcess International All Rights reserved
  • Home
  • Issue Archive
    â–¼
    • Featured Reports
    • eBooks
  • BioProcess Insider
  • Multimedia
    â–¼
    • BPI White Papers
    • Webinars
    • Posters
  • BioProcess International Events
    â–¼
    • BioProcess International US West
    • BioProcess International Europe
  • BioProcess International Academy
  • Events